Actively Recruiting
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
Led by Henry Ford Health System · Updated on 2025-06-26
60
Participants Needed
1
Research Sites
276 weeks
Total Duration
On this page
Sponsors
H
Henry Ford Health System
Lead Sponsor
M
Medtronic
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this research is to combine two complementary modes of treatment, spinal interstitial laser ablation and stereotactic spine radiosurgery (SSRS) for the treatment for spinal tumors near the spinal cord with an objective to improve tumor control, improve pain control, preserve function, and improve quality of life. We will also assess how effective these combined modes of treatment are in patients with spinal metastasis with an epidural component.
CONDITIONS
Official Title
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age > 18 years old
- Histologic diagnosis of solid malignant tumor (non-radiosensitive types) including non-small cell lung cancer, breast, prostate, renal cell, melanoma, gastrointestinal, sarcoma, thyroid, head and neck primary, or unknown primary tumors
- Epidural spinal cord compression graded 1C, 2, or 3 by MRI
- Vertebral body site to be treated located from T2 to L1
- No more than 3 vertebral levels involved with metastasis to be irradiated in one or three sessions
- Motor strength 4 or higher out of 5 in affected limbs
- ECOG performance status less than 2 or Karnofsky performance status greater than 50
- Life expectancy greater than 3 months
- Disease is inoperable due to refusal, neurosurgical evaluation, or other medical reasons
- Agreement to use adequate contraception during study participation for women of child-bearing potential and men
- Prior conventional radiation allowed if more than 3 months have passed since last treatment at the same site
- Signed informed consent
You will not qualify if you...
- Requires open spinal procedure or percutaneous procedure without image guidance
- Primary tumors with radiosensitive histology such as lymphoma, multiple myeloma, small cell carcinoma, germ cell tumors
- Unable to tolerate general anesthesia and prone position
- Unable to undergo MRI scan of the spine
- Unable to lie flat on a treatment table for more than 60 minutes
- Pregnant
- Prior conventional radiation to the spine site with less than 3 months interval
- Severe cord compression from bone or configuration causing acute neurological deficits with motor strength less than 4 out of 5 in affected limbs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Henry Ford Hospital
Detroit, Michigan, United States, 48202
Actively Recruiting
Research Team
R
RAMONA DAVIS
CONTACT
R
REHNUMA NEWAZ
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here